Abstract
The study compared visual evoked potentials of patients with uncomplicated Graves' ophthalmopathy, patients with ophthalmopathy and elevated intraocular pressure or suspect glaucoma, and patients with dysthyroid optic neuropathy (DON). The aim of the study was to investigate the clinical potential for the visual evoked potentials (VEP) in the differential diagnosis among the groups. The VEPs were obtained from 43 subjects with endocrine ophthalmopathy. Group I included patients with uncomplicated ophthalmopathy (30 eyes); group II included patients with ophthalmopathy, intraocular pressure ≥ 23 mmHg with and without early visual field defects, and no evidence of apical crowding on coronal computed tomography scan (28 eyes); group III included patients with DON (28 eyes). Amplitude and latency of major component of pattern VEP were obtained at three visual angles (60', 30', 15'). Data from each group was compared with data from age-matched normal subjects. Disturbances of VEP were found mainly in patients of Group II and Group III. Control Group had normal VEP. About the differential diagnosis between Group II and Group III the most important parameter was the N75-P100 amplitude for 15' of pattern stimulation. Only for this visual angle, Group II and Group III had not overlapped N75-P100 amplitude. This study shows that VEP detect visual function abnormalities noninvasively in patients with complicated Graves' ophthalmopathy. Results also indicate the clinical potential for VEP in the differential diagnosis between patients suffering from ophthalmopathy complicated by ocular hypertension or suspect glaucoma and patients with dysthyroid optic neuropathy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Jacobson DH, Gorman CA. Endocrine ophthalmopathy: Current ideas concerning etiology, pathogenesis, and treatment. Endocrine Rev 1984; 5: 200–20.
Fells P. Orbital decompression for severe dysthyroid eye disease. Br J Ophthalmol 1987; 71: 107–11.
Neigel JM, Rootman J, Belkin RI, Nugent RA, Drance SM, Beattie CW, Spinelli JA. Dysthyroid optic neuropathy. The crowded apex syndrome. Ophthalmology 1988; 95: 1515–21.
Leone CR Jr. The management of ophthalmic Graves' disease. Ophthalmology 1984; 91: 770–9.
Trobe JD, Glaser JS, Laflamme P. Dysthyroid optic neuropathy. Clinical profile and rationale for management. Arch Ophthalmol 1978; 96: 1199–209.
Manor RS, Kurz O, Lewitus Z. Intraocular pressure in endocrinological patients with exophthalmos. Ophthalmologica 1974; 168: 241–52.
Ohtsuka K. Intraocular pressure and proptosis in 95 patients with Graves' ophthalmopathy. Am J Ophthalmol 1997; 124(4): 570–2.
Jamsen K. Thyroid disease, a risk factor for optic neuropathy mimicking normal-tension glaucoma. Acta Ophthalmol Scand 1996; 74(5): 456–60.
Parisi V, Manni G, Spadaro M, Colacino G, Restuccia R, Marchi S, Bucci MG, Pierelli F. Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci 1999; 40(11): 2520–7.
Janaky M, Benedek G. Visual evoked potentials during the early phase of optic nerve compression in the orbital cavity. Doc Ophthalmol 1992; 81(2): 197–208.
Skalka HW. Comparison of Snellen acuity, VER acuity, and Arden grating scores in macular and optic nerve diseases. Br J Ophthalmol 1980; 64: 24–9.
Neigel JM, Rootman J, Belkin RI, Neugent RA, Drancl SM, Beattie CW. Dysthyroid optic neuropathy, the crowed orbital apex syndrome. Ophthalmology 1998; 95: 1515–21.
Setala K, Raitta C, Valimaki M, Katevuo V, Lamberg BA. The value of visual evoked potentials in optic neuropathy of Graves' disease. J Endocrinol Invest 1992; 15(11): 821–6.
Tsaloumas MD, Good PA, Burdon MA, Misson GP Flash and pattern visual evoked potentials in the diagnosis and monitoring of dysthyroid optic neuropathy. Eye 1994; 8: (Pt 6): 638–45.
Greenstein VC, Seliger S, Zemon V, Ritch R. Visual evoked potential assessment of the effects of glaucoma on visual subsystems. Vision Res 1998; 38(12): 1901–11.
Iester M, Altieri M, Capris P, Zingirian M, Traverso CE. Comparison between relative dispersion analysis of high-pass resolution perimetry and standard threshold perimetry. Eye 2000; 5: 742–6.
Werner SC. Modification of the classification of the eye changes of Graves' disease: Recommendations of the ad hoc committee of the American Thyroid Association. J Clin Endocrinol Metabol 1977; 44: 203–4.
Harding GFA, Odom JV, Spileers W, Spekreijse H. Standard for visual evoked potentials. Vision Res 1996; 36: 3567–72.
Ambrosio G, De Marco R, Loffredo L, Magli A. Visual dysfunction in patients with mitochondrial myopathies. Doc Ophthalmol 1995; 89: 211–8.
Hallin ES, Feldon SE. Graves' ophthalmopathy: II. Correlation of clinical signs with measures derived for computed tomography. Br J Ophthalmol 1988; 72: 678–82.
Ossoinig KC. Ultrasound diagnosis of Graves' ophthalmopathy. In: Gorman CA, Walter RR, Dyer JA, eds. The Eye and Orbit in Thyroid Disease. New York: Raven Press, 1984, 185–211.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ambrosio, G., Ferrara, G., Vitale, R. et al. Visual evoked potentials in patients with Graves' ophthalmopathy complicated by ocular hypertension and suspect glaucoma or dysthyroid optic neuropathy. Doc Ophthalmol 106, 99–104 (2003). https://doi.org/10.1023/A:1022561530782
Issue Date:
DOI: https://doi.org/10.1023/A:1022561530782